Literature DB >> 26838367

[Serious infections in patients with rheumatoid arthritis].

E Märker-Hermann1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26838367     DOI： 10.1007/s00108-015-0012-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  4 in total

Review 1.  European biologicals registers: methodology, selected results and perspectives.

Authors:  A Zink; J Askling; W G Dixon; L Klareskog; A J Silman; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

Review 2.  The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.

Authors:  Joachim Listing; Kerstin Gerhold; Angela Zink
Journal:  Rheumatology (Oxford)       Date:  2012-11-28       Impact factor: 7.580

3.  Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Authors:  A Strangfeld; M Eveslage; M Schneider; H J Bergerhausen; T Klopsch; A Zink; J Listing
Journal:  Ann Rheum Dis       Date:  2011-07-25       Impact factor: 19.103

4.  Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

Authors:  Maxime Dougados; Martin Soubrier; Anna Antunez; Peter Balint; Alejandro Balsa; Maya H Buch; Gustavo Casado; Jacqueline Detert; Bassel El-Zorkany; Paul Emery; Najia Hajjaj-Hassouni; Masayoshi Harigai; Shue-Fen Luo; Reka Kurucz; Gabriel Maciel; Emilio Martin Mola; Carlo Maurizio Montecucco; Iain McInnes; Helga Radner; Josef S Smolen; Yeong-Wook Song; Harald Erwin Vonkeman; Kevin Winthrop; Jonathan Kay
Journal:  Ann Rheum Dis       Date:  2013-10-04       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.